- Hannover Re’s 1Q EBIT has missed estimates, coming in at EU810.5 million instead of the predicted EU820.8 million.
- The net income for the same period was EU558.1 million, falling slightly behind the estimate of EU567.5 million.
- However, the company’s performance was better in the Property & Casualty Combined ratio, registering at 88% instead of the estimated 90.9%.
- Hannover Re also saw a significant Return on Equity of 21.3%.
- The market response to these results has seen a mix of reactions with 7 buys, 7 holds and 6 sells.
A look at Hannover Rueck Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 4 | |
| Growth | 4 | |
| Resilience | 3 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.6 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on the Smartkarma Smart Scores, Hannover Rueck SE seems to have a promising long-term outlook. The company scores well across different factors, with solid scores in Dividend, Growth, Resilience, and Momentum. Hannover Rueck SE provides a range of reinsurance services, including life, health, accident, damage, property, and high-risk specialty reinsurance. With its strong outlook in dividend, growth, resilience, and momentum, Hannover Rueck SE appears to be positioned well for sustained success in the future.
Investors looking for a company with a balanced mix of value, growth, and reliable dividends may find Hannover Rueck SE an attractive option based on the Smartkarma Smart Scores. The company’s strong performance in key areas such as dividend, growth, resilience, and momentum underscores its potential for long-term success in the reinsurance industry. With a focus on providing various reinsurance services, including high-risk specialty reinsurance, Hannover Rueck SE’s overall outlook appears positive, supported by its favorable scores across important performance metrics.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
